Related Experiment Video
Updated: Sep 7, 2025

Spectrophotometric Screening for Potential Inhibitors of Cytosolic Glutathione S-Transferases
Published on: October 10, 2020
O-GlcNAc transferase maintains metabolic homeostasis in response to CDK9 inhibition
Aishwarya Gondane1, Ninu Poulose2,3, Suzanne Walker4
1Department of Biochemistry and Developmental Biology, Faculty of Medicine, University of Helsinki, Helsinki 00014, Finland.
Abstract:
Co-targeting of O-GlcNAc transferase (OGT) and the transcriptional kinase cyclin-dependent kinase 9 (CDK9) is toxic to prostate cancer cells. As OGT is an essential glycosyltransferase, identifying an alternative target showing similar effects is of great interest. Here, we used a multiomics approach (transcriptomics, metabolomics, and proteomics) to better understand the mechanistic basis of the combinatorial lethality between OGT and CDK9 inhibition. CDK9 inhibition preferentially affected transcription. In contrast, depletion of OGT activity predominantly remodeled the metabolome. Using an unbiased systems biology approach (weighted gene correlation network analysis), we discovered that CDK9 inhibition alters mitochondrial activity/flux, and high OGT activity is essential to maintain mitochondrial respiration when CDK9 activity is depleted. Our metabolite profiling data revealed that pantothenic acid (vitamin B5) is the metabolite that is most robustly induced by both OGT and OGT+CDK9 inhibitor treatments but not by CDK9 inhibition alone. Finally, supplementing prostate cancer cell lines with vitamin B5 in the presence of CDK9 inhibitor mimics the effects of co-targeting OGT and CDK9.
Insights
Combining O-GlcNAc transferase (OGT) and cyclin-dependent kinase 9 (CDK9) inhibition is toxic to prostate cancer. Vitamin B5 supplementation mimics this combined effect with CDK9 inhibition, offering a potential therapeutic strategy.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Co-targeting O-GlcNAc transferase (OGT) and cyclin-dependent kinase 9 (CDK9) demonstrates toxicity in prostate cancer cells.
- OGT is an essential glycosyltransferase, making the identification of alternative therapeutic targets crucial.
Purpose of the Study:
- To elucidate the mechanistic underpinnings of the combined lethality induced by OGT and CDK9 inhibition.
- To explore the distinct and overlapping roles of OGT and CDK9 in prostate cancer cell biology.
Main Methods:
- Utilized a multiomics approach, including transcriptomics, metabolomics, and proteomics.
- Employed weighted gene correlation network analysis (WGCNA) for systems biology insights.
- Conducted metabolite profiling and cell-based supplementation assays.
Main Results:
- CDK9 inhibition primarily impacted transcription, while OGT depletion significantly remodeled the metabolome.
- CDK9 inhibition disrupted mitochondrial activity, and OGT activity was vital for maintaining mitochondrial respiration under CDK9 inhibition.
- Pantothenic acid (vitamin B5) was identified as a key metabolite induced by OGT inhibition and combined OGT/CDK9 inhibition.
Conclusions:
- High OGT activity is essential for maintaining mitochondrial function when CDK9 is inhibited.
- Supplementation with vitamin B5 alongside CDK9 inhibition effectively replicates the cytotoxic effects of simultaneously targeting OGT and CDK9 in prostate cancer cells.
- This suggests a potential therapeutic avenue involving vitamin B5 and CDK9 inhibitors for prostate cancer treatment.
More Related Videos
13:15Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1
Published on: February 25, 2016
08:04Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
Published on: October 23, 2018
Related Concept Videos
Inhibition of Cdk Activity
cAMP-dependent Protein Kinase Pathways
Positive Regulator Molecules
GPCRs Regulate Adenylyl Cylase Activity
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Global Regulatory Systems